Marketing & Strategy
AstraZeneca reveals success behind company’s recognition at the PRIME Awards
Marketing & Strategy: The annual PRIME Awards were recently celebrated by the industry and recognised the best and brightest in […]
MoreMarketing & Strategy
PRIME Awards 2021 winners announced
Marketing & Strategy: The 17th annual PRIME Awards were celebrated by the industry, together and in-person on Thursday the 25th […]
MoreMarketing & Strategy
PRIME Awards 2021 finalists announced
The finalists for PRIME Awards 2021 have been named, with winners to be announced at the awards night on Thursday […]
MoreMarketing & Strategy
How a HCP initiated engagement model could be the way forward for the pharma industry
Marketing & Strategy: The sudden and ongoing impact of COVID-19 on professional face-to-face interaction, along with the already evolving transition […]
MoreMarketing & Strategy
Top tips for an award winning entry – Interview with Chair of Judges, PRIME Awards 2021
Marketing & Strategy: The PRIME Awards returns in 2021 to recognise and celebrate excellence within healthcare communications in the Australian […]
MoreMarketing & Strategy
Bayer’s patient program improves treatment persistence and adherence
Marketing & Strategy: A leading patient outcomes journal has published a study that demonstrates significant improvement in treatment behaviours among patients […]
MoreMarketing & Strategy
Patient engagement with clinicians doubles on Twitter
Marketing & Strategy: Patient-clinician engagement using Twitter has nearly doubled since the start of the COVID-19 pandemic and doctors are […]
MoreMarketing & Strategy
Reimagine the ‘new normal’ of HCP engagement
Marketing & Strategy: The greatest danger in times of turbulence is not the turbulence, it is to act with yesterday’s […]
MoreMarketing & Strategy
The evolution of HCP engagement – COVID-19 recovery phase
Please log in to Health Industry Hub to view this content in Marketing & Strategy sub-menu.
Marketing & Strategy
The success behind PRIME Awards winner Continuity of Care Collaboration
e-News Bulletin for Pharma, MedTech & Biotech
Oops! You need to be logged in to use this form.Recent Posts in Pharma, MedTech & Biotech
PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals
January 17, 2022
in Human Resources
Stryker announces fellowships for medtech partner projects
January 17, 2022
in News & Trends - Medical Technology
New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients
January 17, 2022
in News & Trends - Pharmaceuticals
Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma
January 17, 2022
in News & Trends - Pharmaceuticals
Hollywood Private Hospital top recruiting site for global Moderna melanoma clinical trial
January 17, 2022
in News & Trends - Biotechnology
Medtronic to acquire cardiac arrhythmia devicemaker for $925M
January 14, 2022
in News & Trends - Medical Technology
Gilead’s CAR T-cell therapy heralds a paradigm shift in B-cell lymphoma
January 14, 2022
in News & Trends - Pharmaceuticals
Sydney private hospital a first mover with breakthrough technology in urology
January 14, 2022
in News & Trends - Medical Technology
Follow Us
Partner with us
Human Resources
PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals
Human Resources: In this Health Industry Hub podcast, Medicines Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs reflect on their contribution […]
MoreNews & Trends - Medical Technology
Stryker announces fellowships for medtech partner projects
MedTech News: Stryker announced two of its partner research projects have secured fellowship funding from the Australian government’s Researcher Exchange […]
MoreNews & Trends - Pharmaceuticals
New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients
Pharma News: Update to international guidelines recommend two new drugs for the treatment of COVID-19. Eli Lilly’s oral JAK inhibitor, […]
MoreNews & Trends - Pharmaceuticals
Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma
Pharma News: Novartis’ chimeric antigen receptor (CAR) T-cell therapy was not found to improve event-free survival over what was seen […]
More